Videos

At ONS Congress 2026, Elianna Tobin shared how nurse navigator outreach helped patients feel more prepared before cancer appointments.

Learn the risk factors, symptoms and screening options tied to colorectal cancer as cases continue rising among younger adults.

Patients receiving immunotherapy may develop lifelong endocrine adverse effects requiring insulin, hormone therapy and ongoing support.

Two-time acute myeloid leukemia survivor Amanda Ferraro teamed up with CURE to share the 10 things that helped her get through cancer treatment — offering hope, strength and support for others navigating their own journey.

Michele Kranz, discussed how oncology nurse navigators like herself support patients with cancer through education, advocacy and care coordination.

Melanoma patients preparing for inpatient TIL therapy learn what to pack, how chemo feels, and how IL‑2 side effects are managed.

Practical guidance eases anxiety before inpatient TIL therapy for melanoma, explaining chemo, infusion, IL-2 side effects, and how to prepare for hospitalization.

Patients should be mindful of preserving muscle mass while receiving GLP-1 therapy during cancer treatment. Experts discuss body composition, sarcopenia and treatment durability in oncology care.

Researchers at Moffitt Cancer Center are studying DYV800, a topical cream designed to reduce tumor acidity and help the immune system fight cancer.

Dr. Susan MacDonald breaks down the TNM staging system (Tumor, Nodes, Metastasis) to help patients understand their clinical diagnosis.

A USC study finds immunotherapy increases PAD risk by 60%. Experts advise vascular monitoring to help prevent limb loss in cancer survivors.

Subcutaneous immunotherapy for melanoma cuts clinic time, boosts comfort and autonomy, and helps patients keep work, family, and passions.

Patients welcome subcutaneous immunotherapy for shorter clinic time, with the same monitoring—reshaping expectations of cancer care.

Oncology dietitians shared smoothie and turmeric latte recipes to help patients with breast cancer manage nutrition during treatment.

MD Anderson’s trial uses psilocybin and psychotherapy to treat cancer-related anxiety, helping patients thrive through neuroplasticity.

After a devastating pancreatic cancer diagnosis, Sharon chose a personalized treatment path that helped inspire future research.

Patient recounts IL‑2 therapy chills, rigors, ICU seizure scare, and recovery—what treatment feels like and why monitoring matters.

Inside TIL therapy: daily hospital routines, caregiver support, chemo and infusion steps, and what recovery questions patients ask most.

Logan Terry, who has stage 4 ALK-positive lung cancer, encouraged patients with cancer to keep living fully after diagnosis and not be defined by fear or bitterness.

Dr. Samyukta Mullangi shares how AI can help patients understand oncology visits, ask better questions, and feel more engaged in their care.

CURE spoke with Dr. Michael E. Kasper, medical director of radiation oncology at the Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital.

Rutgers researchers find tactical problem-solving significantly lowers anxiety and empowers young adult cancer patients to manage developmental stressors.

Discover how subcutaneous melanoma immunotherapy replaces IV infusions, cutting clinic time while delivering the same proven drug and results.

IV vs subcutaneous nivolumab feels similar, experts say—watch the same toxicity labs, and calm mild injection-site reactions with ice or Benadryl.

Dr. Ginger J. Gardner highlights the vital role of caregivers in cancer care, emphasizing support gaps, shared experiences and patient-centered solutions.

A patient details diagnosis, transplant treatment and the complex path to recovery and survivorship after leukemia.

Inside a TIL therapy hospital stay: daily routines, caregiver support, and what to expect from chemo, infusion, and recovery.

A patient recounts sudden vision changes leading to brain tumor surgery and a switch from immunotherapy to targeted therapy and new TIL treatment.

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies.

KRAS was long thought undruggable in cancer until scientists discovered a hidden binding pocket in mutant KRAS, leading to targeted therapies.